Glucose-induced regulation of novel iron transporters in vascular endothelial cell dysfunction

References

• Aleksandrovski YA. Molecular mechanisms of diabetic complications. Biochemistry (Mosc) 1998; 63: 1249–1257
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 2002; 288: 2579–2588
   PubMed Web of Science ®Google Scholar
• Khan ZA, Chakrabarti S. Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 2003; 81: 622–634
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Khan ZA, Cukiernik M, Fukuda G, Chen S, Mukherjee S. Alteration of endothelins: A common pathogenetic mechanism in chronic diabetic complications. Int J Exp Diabetes Res 2002; 3: 217–231
   PubMedGoogle Scholar
• Laight DW, Carrier MJ, Anggard EE. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev 1999; 15: 274–282
   PubMed Web of Science ®Google Scholar
• Khan ZA, Cukiernik M, Gonder JR, Chakrabarti S. Oncofetal fibronectin in diabetic retinopathy. Investig Ophthalmol Vis Sci 2004; 45: 287–295
   PubMed Web of Science ®Google Scholar
• Chen S, Apostolova MD, Cherian MG, Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Investig 2000; 80: 1311–1321
   PubMed Web of Science ®Google Scholar
• Xin X, Khan ZA, Chen S, Chakrabarti S. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Investig 2004; 84: 1451–1459
   PubMedGoogle Scholar
• Chen S, Mukherjee S, Chakraborty C, Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol 2003; 284: C263–C272
   Google Scholar
• Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, Hedrick CC. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004; 47: 1727–1734
   PubMed Web of Science ®Google Scholar
• Weidig P, McMaster D, Bayraktutan U. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes Metab 2004; 6: 432–441
   PubMed Web of Science ®Google Scholar
• Ogita H, Liao J. Endothelial function and oxidative stress. Endothelium 2004; 11: 123–132
   PubMed Web of Science ®Google Scholar
• Farhangkhoee H, Khan ZA, Mukherjee S, Cukiernik M, Barbin YP, Karmazyn M, Chakrabarti S. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 2003; 35: 1439–1448
   PubMed Web of Science ®Google Scholar
• Andrews NC. Metal transporters and disease. Curr Opin Chem Biol 2002; 6: 181–186
   PubMed Web of Science ®Google Scholar
• Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383–386
   PubMed Web of Science ®Google Scholar
• Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482–488
   PubMed Web of Science ®Google Scholar
• McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299–309
   PubMed Web of Science ®Google Scholar
• Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus IL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403: 776–781
   PubMed Web of Science ®Google Scholar
• Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275: 19906–19912
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 2004; 350: 2383–2397
   PubMed Web of Science ®Google Scholar
• Koo SW, Casper KA, Otto KB, Gira AK, Swerlick RA. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells. J Investig Dermatol 2003; 120: 871–879
   PubMed Web of Science ®Google Scholar
• Khan ZA, Barbin YP, Cukiernik M, Adams PC, Chakrabarti S. Heme-oxygenase-mediated iron accumulation in the liver. Can J Physiol Pharmacol 2004; 82: 448–456
   PubMedGoogle Scholar
• McLean M, Bowman M, Clifton V, Smith R, Grossman AB. Expression of the heme oxygenase-carbon monoxide signalling system in human placenta. J Clin Endocrinol Metab 2000; 85: 2345–2349
   PubMed Web of Science ®Google Scholar
• Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trmpisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256–1262
   PubMed Web of Science ®Google Scholar
• Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991; 101: 368–372
   PubMed Web of Science ®Google Scholar
• Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655–659
   PubMed Web of Science ®Google Scholar
• Niederau C, Fisher R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107–1119
   PubMed Web of Science ®Google Scholar
• Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004; 291: 711–717
   PubMed Web of Science ®Google Scholar
• Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5: 113–124
   PubMed Web of Science ®Google Scholar
• Wolff SP. Diabetes mellitus and free radicals: Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993; 49: 642–652
   PubMed Web of Science ®Google Scholar
• Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among US adults. Diabetes Care 1999; 22: 1978–1983
   PubMed Web of Science ®Google Scholar
• Heikkila RE, Cabbat FS. The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac: Suggestion of a role for iron in the cytotoxic process. Experientia 1982; 38: 378–379
   PubMedGoogle Scholar
• Hattori N, Schnell O, Bengel FM, Rihl J, Nekolla SG, Drzezga AE, Standl E, Schwaiger M. Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus. Eur J Nucl Med Mol Imaging 2002; 29: 891–898
   PubMedGoogle Scholar
• Pieper GM, Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 1997; 30: 734–738
   PubMed Web of Science ®Google Scholar
• Zacharski LR, Gerhard GS. Atherosclerosis: A manifestation of chronic iron toxicity?. Vasc Med 2003; 8: 153–155
   PubMedGoogle Scholar
• Rossi E, McQuillan BM, Hung J, Thompson PL, Kuek C, Beilby JP. Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population. Stroke 2000; 31: 3015–3020
   PubMedGoogle Scholar
• Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, Banga JD. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999; 100: 1268–1273
   PubMed Web of Science ®Google Scholar